ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
3,816
Screening encounters
4,484
Diagnostic referrals
853
Outstanding pathways
308

Screening pathway

  1. Screening4,484Encounters
  2. Positive finding1,547Documented findings
  3. Referral853Diagnostic referrals
  4. Follow-up1,012Diagnostic visits
  5. Outcome545Resolved pathways

Stage totals use different units. Pending pathways: 308. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0085 · EXP-0085Synthetic · Site E

Full participant history through 2026-11-12, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-11-28
  4. · Diagnostic referral · EXP-0085-T-R
  5. · Contact attempt · Reached
  6. · Diagnostic booking · Initial booking
  7. · Barrier documented · Contact difficulty
  8. · Navigation intervention · Coordination support
  9. · Diagnostic visit · Attended
  10. · Diagnosis · Colposcopy · Biopsy collected
  11. · Diagnosis · Histopathology · High-grade lesion
  12. · Follow-up disposition · Resolved · EXP-0085-T-R
  13. · Treatment · Synthetic precancer treatment
  14. · Surveillance plan · HPV DNA · After treatment · Scheduled for 2027-09-06

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

3816 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0064 · Expanded synthetic participant 0064Site E — Resource-Constrained Navigation Programme
EXP-0065 · Expanded synthetic participant 0065Site A — Urban Referral Hub
EXP-0066 · Expanded synthetic participant 0066Site C — Rural Outreach Programme
EXP-0067 · Expanded synthetic participant 0067Site C — Rural Outreach Programme
EXP-0068 · Expanded synthetic participant 0068Site B — Peri-Urban Access Programme
EXP-0069 · Expanded synthetic participant 0069Site E — Resource-Constrained Navigation Programme
EXP-0071 · Expanded synthetic participant 0071Site C — Rural Outreach Programme
EXP-0072 · Expanded synthetic participant 0072Site C — Rural Outreach Programme
EXP-0073 · Expanded synthetic participant 0073Site E — Resource-Constrained Navigation Programme
EXP-0074 · Expanded synthetic participant 0074Site D — Community Engagement Programme
EXP-0075 · Expanded synthetic participant 0075Site A — Urban Referral Hub
EXP-0076 · Expanded synthetic participant 0076Site E — Resource-Constrained Navigation Programme
EXP-0077 · Expanded synthetic participant 0077Site C — Rural Outreach Programme
EXP-0078 · Expanded synthetic participant 0078Site D — Community Engagement Programme
EXP-0079 · Expanded synthetic participant 0079Site B — Peri-Urban Access Programme
EXP-0080 · Expanded synthetic participant 0080Site C — Rural Outreach Programme
EXP-0081 · Expanded synthetic participant 0081Site B — Peri-Urban Access Programme
EXP-0082 · Expanded synthetic participant 0082Site D — Community Engagement Programme
EXP-0084 · Expanded synthetic participant 0084Site D — Community Engagement Programme
EXP-0085 · Expanded synthetic participant 0085Site E — Resource-Constrained Navigation Programme
EXP-0089 · Expanded synthetic participant 0089Site C — Rural Outreach Programme
EXP-0090 · Expanded synthetic participant 0090Site A — Urban Referral Hub
EXP-0091 · Expanded synthetic participant 0091Site C — Rural Outreach Programme
EXP-0092 · Expanded synthetic participant 0092Site C — Rural Outreach Programme
EXP-0093 · Expanded synthetic participant 0093Site B — Peri-Urban Access Programme

Programme insights

Encounters by modality

VIA
1722
HPV DNA
2132
Cytology
630

Navigation activity

Barrier documented
760
Contact attempt
1255
Navigation intervention
326
Diagnostic booking
1064
Diagnostic visit
1012

Documented barriers

Contact difficulty
246
Transport difficulty
250
Appointment coordination
264

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.